RPTOR | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19 results for “RPTOR”

Trials

View all 13 →

Not yet recruiting

Rotor Modulation Ablation for the Treatment of Persistent Atrial Fibrillation

360 participants · First posted Aug 6, 2024

RPTR-147 in Patients With Selected Solid Tumors and Lymphomas

23 participants · First posted Jan 24, 2019

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion (CAPITAL-RAPTOR)

700 participants · First posted Jun 1, 2022

Drugs

RPTR-168

RPTR-147-2

RPTR-168-1

Organizations

Raptor Pharmaceuticals, Inc.

United States

News

Oncotelic Therapeutics Joint Venture Identifies Biomarker Signature for Precision mTOR Inhibitor Therapy

Page 1 of 2